222 related articles for article (PubMed ID: 9506572)
41. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
42. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
[TBL] [Abstract][Full Text] [Related]
43. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery].
Tsukamoto S; Ishikawa S; Yamauchi A; Saitou S
Hinyokika Kiyo; 2000 Oct; 46(10):695-9. PubMed ID: 11215193
[TBL] [Abstract][Full Text] [Related]
44. [Serum soluble interleukin-2 receptor in patients with pulmonary mycobacterial diseases].
Tada A; Kawahara S; Horita N; Horiba A; Tamaoki A; Okada C; Mishima Y; Soda R; Takahashi K
Kekkaku; 1999 Jun; 74(6):499-505. PubMed ID: 10423961
[TBL] [Abstract][Full Text] [Related]
45. [Urine levels of soluble interleukin 2 receptor and free light chain immunoglobulins in lupus nephritis].
Ling SH
Zhonghua Yi Xue Za Zhi; 1993 Dec; 73(12):756-8, 774. PubMed ID: 8143195
[TBL] [Abstract][Full Text] [Related]
46. Soluble interleukin-2-receptor levels as a marker of coronary microvascular dysfunction after heart transplantation.
Weis M; Hartmann A; Scheuermann EH; Olbrich HG
J Heart Lung Transplant; 1998 Mar; 17(3):294-8. PubMed ID: 9563606
[TBL] [Abstract][Full Text] [Related]
47. Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis.
Dalekos GN; Manoussakis MN; Goussia AC; Tsianos EV; Moutsopoulos HM
Gut; 1993 May; 34(5):658-64. PubMed ID: 8504967
[TBL] [Abstract][Full Text] [Related]
48. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome.
Jakiela B; Szczeklik W; Sokolowska B; Mastalerz L; Sanak M; Plutecka H; Szczeklik A
Rheumatology (Oxford); 2009 Oct; 48(10):1202-7. PubMed ID: 19643727
[TBL] [Abstract][Full Text] [Related]
49. The serum levels of soluble interleukin-2 receptor levels in patients with obstructive jaundice.
Yüceyar H; Kokuludag A; Coker A; Ersöz G; Keskinoglu A; Güler A; Cavusoglu H
Hepatogastroenterology; 1996; 43(10):949-53. PubMed ID: 8884319
[TBL] [Abstract][Full Text] [Related]
50. [Changes in serum eosinophil cation protein level and blood eosinophil density in patients with asthma].
Wang H; Sun B
Zhonghua Nei Ke Za Zhi; 1995 Dec; 34(12):802-4. PubMed ID: 8731855
[TBL] [Abstract][Full Text] [Related]
51. Monitoring of serologic immune parameters in inflammatory skin diseases.
Gebhardt M; Wenzel HC; Hipler UC; Herrmann D; Wollina U
Allergy; 1997 Nov; 52(11):1087-94. PubMed ID: 9404560
[TBL] [Abstract][Full Text] [Related]
52. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
[TBL] [Abstract][Full Text] [Related]
53. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
[TBL] [Abstract][Full Text] [Related]
54. Soluble interleukin 2 receptor levels in children with type I insulin-dependent diabetes mellitus.
Gartner LA; Pfeifer MC; Albini C; Francis GL
Ann Clin Lab Sci; 1995; 25(1):44-51. PubMed ID: 7762968
[TBL] [Abstract][Full Text] [Related]
55. Extracorporeal photochemotherapy in patients with cutaneous T-cell lymphoma: is clinical response predictable?
Rao V; Ryggen K; Aarhaug M; Dai HY; Jørstad S; Moen T
J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1100-7. PubMed ID: 16987266
[TBL] [Abstract][Full Text] [Related]
56. Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers.
Frijns R; Fijnheer R; Schiel A; Donders R; Sixma J; Derksen R
J Rheumatol; 2001 Mar; 28(3):514-9. PubMed ID: 11296951
[TBL] [Abstract][Full Text] [Related]
57. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity.
Schmitt WH; Heesen C; Csernok E; Rautmann A; Gross WL
Arthritis Rheum; 1992 Sep; 35(9):1088-96. PubMed ID: 1418025
[TBL] [Abstract][Full Text] [Related]
58. Serum markers of T cell activation in relapses of Wegener's granulomatosis.
Stegeman CA; Tervaert JW; Huitema MG; Kallenberg CG
Clin Exp Immunol; 1993 Mar; 91(3):415-20. PubMed ID: 8443965
[TBL] [Abstract][Full Text] [Related]
59. Elevated serum levels of soluble interleukin-2 receptors in HIV infection: no correlation with activated T cells.
Lang JM; Coumaros G; Levy S; Falkenrodt A; Steckmeyer M; Partisani M; Aleksijevic A; Lehr L; Koehl C
Nouv Rev Fr Hematol (1978); 1989; 31(1):9-11. PubMed ID: 2783774
[TBL] [Abstract][Full Text] [Related]
60. Increased serum soluble interleukin 2 receptor levels in patients with viral liver diseases.
Yamaguchi S; Onji M; Ohta Y
Hepatogastroenterology; 1988 Oct; 35(5):245-8. PubMed ID: 3068111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
